title: A Brief Up-Date of the Use of Sodium Oxybate for the Treatment of Alcohol Use Disorder.
abstract: The treatment of alcohol use disorder (AUD) with sodium oxybate (SMO) or gamma-hydroxybutyric acid (GHB) was introduced in Italy and Austria more than 20 years and 15 years ago, respectively, and it is now widely employed to treat alcohol withdrawal syndrome (AWS) and to maintain alcohol abstinence. These indications derive from its similar structure to the inhibitory neurotransmitter γ-amino-butyric acid (GABA), exerting an ethanol-mimicking effect, because it binds to GABAB receptors. Craving for, and abuse of, SMO remain a controversial issue; even though these unfavorable effects are evident in poly-drug addicted patients and in those with psychiatric diagnosis of borderline personality disorder. In addition, despite cases of severe intoxication and deaths being widely documented when GHB is used as "street drug"; its clinical use remains safe. Thus, the aim of the present review is to examine the role of SMO in the treatment of AUD, its possible implications in reducing alcohol consumption, and cases of abuse, and severe intoxication due to SMO during its clinical use in the treatment of AUD.
authors.affiliation: Department of Internal Medicine, SS Annunziata Hospital, Cento, Ferrara 44042, Italy. f.caputo@ausl.fe.it.|"G. Fontana" Centre for the Study and Multidisciplinary Treatment of Alcohol Addiction, Department of Clinical Medicine, University of Bologna, Bologna 40130, Italy. f.caputo@ausl.fe.it.
authors.forename: Fabio
authors.initials: F
authors.lastname: Caputo
authors.affiliation: Unit for Addiction Treatment, Department of Mental Health, Lugo, Ravenna 48022, Italy. teo.vignoli@ausl.ra.it.
authors.forename: Teo
authors.initials: T
authors.lastname: Vignoli
authors.affiliation: Alcohol Use Disorders Unit, Department of Internal Medicine, Catholic University of Rome, Rome 00168, Italy. claudia.tarli@gmail.com.
authors.forename: Claudia
authors.initials: C
authors.lastname: Tarli
authors.affiliation: "G. Fontana" Centre for the Study and Multidisciplinary Treatment of Alcohol Addiction, Department of Clinical Medicine, University of Bologna, Bologna 40130, Italy. m.domenicali@unibo.it.
authors.forename: Marco
authors.initials: M
authors.lastname: Domenicali
authors.affiliation: Department of Internal Medicine, SS Annunziata Hospital, Cento, Ferrara 44042, Italy. g.zoli@ausl.fe.it.
authors.forename: Giorgio
authors.initials: G
authors.lastname: Zoli
authors.affiliation: "G. Fontana" Centre for the Study and Multidisciplinary Treatment of Alcohol Addiction, Department of Clinical Medicine, University of Bologna, Bologna 40130, Italy. mauro.bernardi@unibo.it.
authors.forename: Mauro
authors.initials: M
authors.lastname: Bernardi
authors.affiliation: Alcohol Use Disorders Unit, Department of Internal Medicine, Catholic University of Rome, Rome 00168, Italy. addolorato@policlinicogemelli.it.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Addolorato
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000428:Alcohol Drinking / Q000188:drug therapy*; D019973:Alcohol-Related Disorders / Q000188:drug therapy*; D000437:Alcoholism / Q000188:drug therapy*; D001317:Austria; D005260:Female; D006801:Humans; D006885:Hydroxybutyrates / Q000627:therapeutic use*; D007558:Italy; D008297:Male; D008875:Middle Aged; D012978:Sodium Oxybate / Q000627:therapeutic use*; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*; D055815:Young Adult
chemical_list: D006885:Hydroxybutyrates; D012978:Sodium Oxybate
keywords: alcohol use disorder; pharmacological treatment; sodium oxybate